Leukemia, Myeloid, Chronic-Phase
"Leukemia, Myeloid, Chronic-Phase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The initial phase of chronic myeloid leukemia consisting of an relatively indolent period lasting from 4 to 7 years. Patients range from asymptomatic to those exhibiting ANEMIA; SPLENOMEGALY; and increased cell turnover. There are 5% or fewer blast cells in the blood and bone marrow in this phase.
| Descriptor ID |
D015466
|
| MeSH Number(s) |
C04.557.337.539.250.400 C15.378.190.636.370.400
|
| Concept/Terms |
Leukemia, Myeloid, Chronic-Phase- Leukemia, Myeloid, Chronic-Phase
- Granulocytic Leukemia, Chronic, Stable-Phase
- Leukemia, Granulocytic, Chronic Phase
- Leukemia, Granulocytic, Chronic-Phase
- Leukemia, Myelogenous, Chronic Phase
- Leukemia, Myelogenous, Chronic-Phase
- Leukemia, Myeloid, Chronic Phase
- Leukemia, Myeloid, Stable Phase
- Leukemia, Myeloid, Stable-Phase
- Myelogenous Leukemia, Chronic, Chronic Phase
- Myelogenous Leukemia, Chronic, Chronic-Phase
- Myeloid Leukemia, Chronic, Chronic Phase
- Myeloid Leukemia, Chronic, Chronic-Phase
- Myeloid Leukemia, Chronic, Stable-Phase
- Granulocytic Leukemia, Chronic, Stable Phase
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Myeloid, Chronic-Phase".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Leukemia [C04.557.337]
- Leukemia, Myeloid [C04.557.337.539]
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive [C04.557.337.539.250]
- Leukemia, Myeloid, Chronic-Phase [C04.557.337.539.250.400]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Bone Marrow Diseases [C15.378.190]
- Myeloproliferative Disorders [C15.378.190.636]
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive [C15.378.190.636.370]
- Leukemia, Myeloid, Chronic-Phase [C15.378.190.636.370.400]
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myeloid, Chronic-Phase".
This graph shows the total number of publications written about "Leukemia, Myeloid, Chronic-Phase" by people in this website by year, and whether "Leukemia, Myeloid, Chronic-Phase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 1 | 3 |
| 1996 | 0 | 1 | 1 |
| 1997 | 2 | 0 | 2 |
| 1998 | 2 | 0 | 2 |
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 1 | 3 |
| 2001 | 0 | 1 | 1 |
| 2002 | 2 | 1 | 3 |
| 2003 | 4 | 0 | 4 |
| 2004 | 4 | 0 | 4 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 4 | 1 | 5 |
| 2008 | 7 | 1 | 8 |
| 2009 | 13 | 0 | 13 |
| 2010 | 13 | 0 | 13 |
| 2011 | 10 | 1 | 11 |
| 2012 | 13 | 0 | 13 |
| 2013 | 11 | 0 | 11 |
| 2014 | 5 | 3 | 8 |
| 2015 | 8 | 1 | 9 |
| 2016 | 12 | 0 | 12 |
| 2017 | 3 | 1 | 4 |
| 2018 | 5 | 0 | 5 |
| 2019 | 5 | 0 | 5 |
| 2020 | 4 | 0 | 4 |
| 2021 | 1 | 0 | 1 |
| 2022 | 5 | 0 | 5 |
| 2023 | 9 | 0 | 9 |
| 2024 | 4 | 2 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Myeloid, Chronic-Phase" by people in Profiles.
-
Treatment of chronic-phase chronic myeloid leukemia in patients randomized to dasatinib or imatinib after suboptimal responses to 3 months of imatinib therapy: final 5-year results from DASCERN. Haematologica. 2024 Oct 01; 109(10):3251-3260.
-
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase. Cancer. 2024 Oct 01; 130(19):3344-3352.
-
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after =1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia. 2024 Jul; 38(7):1522-1533.
-
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia. Cancer. 2024 Aug 01; 130(15):2652-2659.
-
Navigating the Management of Chronic Phase CML in the Era of Generic BCR::ABL1 Tyrosine Kinase Inhibitors. J Natl Compr Canc Netw. 2024 02; 22(1).
-
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia. 2024 03; 38(3):475-481.
-
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921. J Clin Oncol. 2024 Mar 01; 42(7):821-831.
-
Real-World Effectiveness of Dasatinib Versus Imatinib in Newly Diagnosed Patients With Chronic Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2024 03; 24(3):149-157.
-
Population modeling of bosutinib exposure-response in patients with newly diagnosed chronic phase chronic myeloid leukemia. Cancer Med. 2023 09; 12(17):17981-17992.
-
Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis. Haematologica. 2023 06 01; 108(6):1567-1578.